Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene

Christina EL Naaman1, Birgitte Grum-Schwensen, Ahmed Mansouri

  • 1Department of Molecular Cancer Biology, Danish Cancer Society, Strandboulevarden 49, DK2100 Copenhagen, Denmark.

Oncogene
|April 30, 2004
PubMed

Insights

Mice lacking the S100A4 gene developed spontaneous tumors and showed reduced apoptosis. This suggests S100A4 protein is crucial for p53 tumor suppressor function, preventing cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The S100A4 protein, a calcium-binding protein, is implicated in promoting metastasis.
  • The S100A4 gene's role in tumor suppression and its interaction with p53 are not fully understood.

Purpose of the Study:

  • To investigate the in vivo function of S100A4 in tumor suppression.
  • To determine the impact of S100A4 deficiency on p53-mediated apoptosis and tumor development.

Main Methods:

  • Generation of a germ-line S100A4-inactivated mouse model (S100A4-/-).
  • Observation of tumor development, sex ratios, and apoptosis frequency in S100A4-/- mice.
  • Assessment of p53 target gene activation (waf/p21/cip1, bax) post-irradiation.

Main Results:

  • S100A4-/- mice exhibited an abnormal sex ratio, suggesting embryonic lethality.
  • 10% of aged S100A4-/- mice developed spontaneous, p53-positive tumors.
  • Apoptosis frequency and p53 target gene activation were reduced in S100A4-/- mice after irradiation.

Conclusions:

  • S100A4 deficiency leads to functional destabilization of the p53 tumor suppressor.
  • S100A4 plays a critical role in p53-mediated apoptosis and tumor suppression.
  • The S100A4-p53 interaction is essential for preventing spontaneous tumor formation.